ALNY
Alnylam Pharmaceuticals, Inc. · Healthcare
CEO John Maraganore sold $4.6M of Alnylam Pharmaceuticals, Inc.
Sold$4,583,674
$131.85Price
34,765Shares
−15%Stake
What ALNY did after the filing
- The stock from Mon, Feb 24 open, $125.50
- −10.6%
- S&P 500, same days
- −17.6%
Measured over 30 trading days, to the Apr 6 close.
Traded Thu, Feb 20. Filed Fri, Feb 21, 4:02 PM ET, after the close. Returns use the Feb 24 open and the Apr 6 close. Not investment advice.